In contrast to the prior period of time, the Business increased its engineering enterprise by 239% and 203% for the...
Quarter
OneConnect Financial Technology Co., Ltd. NYSE:OCFT SEHK:6638 Earnings Call Monday, May 22, 2023 1:00 PM GMT CALL...
Topline data from MISSION Phase 2 trial of zetomipzomib for the treatment of lupus nephritis expected in June 2022, consistent...
-- First patient dosed in the Phase 1 clinical trial evaluating ACLX-001 utilizing groundbreaking ARC-SparX technology in relapsed or refractory...
Motus GI Holdings, Inc.Pure-Vu EVS approved for use at 11 hospitals since product launch commenced in March 2022; with strong...
GPH101 for sickle cell disease granted U.S. FDA Fast Track Designation; dosing of first patient in Phase 1/2 CEDAR clinical...
